⭐ Start off 2025 with a powerful boost to your portfolio: January’s freshest AI-picked stocksUnlock stocks

Obama urges Congress to approve $6 billion for Ebola fight

Published 12/02/2014, 07:26 PM
© Reuters. Obama tours the Vaccine Research Center during a visit to the National Institutes of Health in Bethesda

By Amanda Becker and Roberta Rampton

BETHESDA, Md./WASHINGTON (Reuters) - President Barack Obama urged Congress on Tuesday to approve $6.18 billion to help fight the Ebola outbreak, reminding them that even though the story has faded from the headlines, the battle against the virus is far from over.

"Every hotspot is an ember that if not contained can become a new fire, so we cannot let down our guard even for a minute," Obama said. "And we can't just fight this epidemic. We have to extinguish it."

Obama toured a lab at the National Institutes of Health, where a team of researchers last week published promising results from the first phase of a research trial for an Ebola vaccine.

Most of Obama's request is aimed at the immediate response to the disease. But the package also includes $1.5 billion in contingency funds - money that could become a target if lawmakers look for cuts, said Sam Worthington, president of InterAction, an alliance of U.S. non-governmental aid groups.

While lawmakers recognize that the United States had to take action to arrest Ebola, some are wary of giving the administration too much leeway.

"I think there is less understanding of the need to stay in it for the long run and to build the capacity of countries to ensure this doesn't happen in the future," Worthington said in an interview.

Obama noted that NIH scientists first began work on research that led to the potential Ebola vaccine in 1999, long before the worst outbreak of the disease on record, which has afflicted more than 17,000 people since March, killing more than 6,000.

He said the United States needs to continue to fund basic research and help nations such as Guinea, Liberia and Sierra Leone build better public health systems so that the world can quickly contain future disease outbreaks.

"It is a smart investment for us to make. It's not just insurance. It is knowing that down the road we're going to continue to have problems like this, particularly in a globalized world where you move from one side of the world to the other in a day," Obama said.

The Obama administration came under fire in September after a series of missteps with a man who traveled to Dallas from Liberia and later died of Ebola. Two nurses contracted the disease while caring for the man.

© Reuters. Obama tours the Vaccine Research Center during a visit to the National Institutes of Health in Bethesda

Screening and treatment procedures have since been tightened. There are now 35 U.S. hospitals equipped to deal with Ebola patients, up from three before the outbreak.

(Additional reporting by Steve Holland; Editing by Lisa Shumaker)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.